Diabetes Nutrition Market, by Form (Fixed Dental Prosthetic (Tablets, Capsules, Powders, Soft Gels, Liquids), by Product Type (Proteins & Amino Acids, Omega-3 Fatty Acids, Alpha-Lipoic Acid (ALA), Herbal Supplements, Soluble Fiber, Probiotics, Carbohydrates, Others (Antioxidants, etc.)), by Age Group (Paediatric, Adults), by Indication (Type 1 Diabetes, Type 2 Diabetes, Prediabetes, Gestational Diabetes), by Sales Channel (Hospitals, Retail Pharmacies, Online Pharmacies and Others (Wholesaler, Convenience Stores, etc.), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
Nutrition and physical activities are the most important aspects for a healthy lifestyle for a diabetic person. A high diet in fat, calories, and cholesterol increases risk of diabetes and a poor diet can lead to obesity which is the other risk factor for diabetes and other health problems. Nutrition is very important part in management of diabetes. Diabetes nutrition products are dietary products that contain less sugar and carbohydrate content. These products help in controlling blood glucose levels. Moreover, diabetes nutrition food contains low calorie diet beverages as well as sweeteners. These nutrition products are mostly consumed by diabetes patient as well non-diabetic patients as precautionary measure to prevent diabetes. These nutrition products also help to regulate other complications of diabetes such as neuropathy, nephropathy, high blood pressure along with diabetes, as these products help to maintain the lipid profile that leads to decrease in the risk of vascular complications. Diabetic patients require a low fat diet containing fruits and vegetables and low fat dairy products containing calcium, potassium, and magnesium.
Market Dynamics
Adoption of inorganic strategies, such as product approval, by regulatory authority such as the U.S. Food and Drug Administration is expected to drive the global diabetes nutrition market growth over the forecast period. For instance, in September 2022, Eli Lilly and Company, a pharmaceutical company, announced that they had received an approval from the U.S. Food and Drug Administration for Mounjaro, a tirzepatide injection treatment for Type 2 diabetes. It is the first and only FDA-approved gastric inhibitory polypeptide and glucagon-like-peptide-1 receptor agonist.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook